Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Seer (Nasdaq: SEER) will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026.

Rhea-AI Summary

Seer (Nasdaq: SEER) will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. Management will host a live webcast and conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Live audio and an archived replay will be available on the company investor website.

Argus Feb 6 session

+2.29% close to close Open Argus

Details

News Market Reaction – SEER

On Feb 6, the first trading day after this news, SEER closed 2.29% above the previous close.

Data tracked by StockTitan Argus for the Feb 6 session.

Key Figures

Earnings date: February 26, 2026 Earnings call time: 1:30 p.m. PT / 4:30 p.m. ET

Earnings date

February 26, 2026

Q4 and full-year 2025 results release

Earnings call time

1:30 p.m. PT / 4:30 p.m. ET

Scheduled webcast conference call

Historical Context

5 past events · Latest: Dec 01

5 events

1. Dec 01

   Platform validation

   24h Move

   -1.0%

   Nature Genetics study validated Proteograph platform and identified novel pQTL signals.

2. Nov 07

   Scientific presentations

   24h Move

   -3.2%

   HUPO 2025 data showcased Proteograph use across multiple disease and biology areas.

3. Nov 06

   Q3 2025 earnings

   24h Move

   -0.5%

   Q3 2025 results with higher revenue, improved loss, and reiterated 2025 guidance.

4. Oct 29

   Investor conferences

   24h Move

   -3.1%

   Planned participation in UBS and Canaccord investor conferences with webcasts.

5. Oct 16

   Earnings date

   24h Move

   -2.3%

   Announcement of Q3 2025 earnings date and webcast timing on Nov 6, 2025.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

proteomic

1 terms

proteomic medical

"the pioneer and trusted partner for deep, unbiased proteomic insights, today announced"

Proteomic describes something related to the large-scale study of proteins—the working parts inside cells that carry out functions and signal changes. For investors, proteomic work can reveal new drug targets, diagnostic tests or biomarkers that change a company’s potential revenue and risk profile; think of it like analyzing all ingredients in a recipe to find which ones can be improved or swapped to make a better product.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the fourth quarter and full year 2025 on Thursday, February 26, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Media Contact:
Patrick Schmidt
pr@seer.bio 

Investor Contact:
investor@seer.bio 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Seer (SEER) report Q4 and full year 2025 financial results?

Seer will report results on Thursday, February 26, 2026, with a management webcast and call starting at 1:30 p.m. PT / 4:30 p.m. ET. According to the company, the event will cover fourth quarter and full year 2025 financial results and commentary.

How can investors listen to Seer (SEER) earnings call on February 26, 2026?

Investors can listen via live audio webcast on Seer’s investor website at investor.seer.bio. According to the company, a live webcast will stream at the scheduled time and an archived replay will be posted afterwards for on-demand access.

What time is Seer (SEER) management’s conference call for the Q4 2025 release?

The conference call begins at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on February 26, 2026. According to the company, management will webcast the call and provide a subsequent archived replay on its investor site.

Will Seer (SEER) make a replay of the February 26, 2026 webcast available?

Yes. An archived replay will be available on Seer’s investor website after the live event. According to the company, the replay will be posted on the company website following the webcast for later review.